Announcing the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project


The Fleming Fund is delighted to announce the MAAP project initiated through round one of the Regional Grant programme.

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project is being undertaken through a consortium of the African Society for Laboratory Medicine (ASLM), the Center for Disease Dynamics, Economics & Policy (CDDEP), IQVIA Solutions (Pty) Ltd , Africa CDC, West African Health Organisation (WAHO), the Eastern, Central and Southern African Community (ECSA) and Innovative Support to Emergencies, Diseases and Disasters (InSTEDD).

The MAAP project is funded through the Fleming Fund's Regional Grants programme and the project aims to collect and share data on antimicrobial resistance (AMR) and antimicrobial use (AMU), initially across 12 countries in West, East and Southern Africa. Specifically the MAAP project will:

The MAAP grant activity will align with other Fleming Fund Regional Grant in Asia and the Global AMR Research (GRAM) project, whilst supporting the Country Grant programme in the region.

More Like This

The Regional Grant for South Asia and South East Asia has been awarded to an International Vaccine Institute led consortium to undertake the CAPTURA project.

On 24th and 25th June 2021, the Tropical Health and Education Trust ([THET](https://www.thet.org/)) and the Commonwealth Pharmacists Association ([CPA](https://commonwealthpharmacy.org/)) hosted a two-day sharing and learning event which brought together over 100 delegates from across the global health community to celebrate and showcase the work of the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) grant holders and the programmatic level outputs.